CVRx to Present at the William Blair 44th Annual Growth Stock Conference
22 May 2024 - 10:30PM
CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical
device company, today announced that the management team will
present at the William Blair 44th Annual Growth Stock Conference on
Wednesday, June 5, 2024. The Company is scheduled to present at
8:40am Central Time the same day via webcast.
A live audio webcast of the conference presentation will be
available online at the investor relations page of the Company’s
website at ir.cvrx.com.
About CVRx, Inc.
CVRx is focused on the development and commercialization of the
Barostim™ System, the first medical technology approved by FDA that
uses neuromodulation to improve the symptoms of heart failure.
Barostim is an implantable device that delivers electrical pulses
to baroreceptors located in the wall of the carotid artery.
Baroreceptors activate the body's baroreflex, which in turn
triggers an autonomic response to the heart. The therapy is
designed to restore balance to the autonomic nervous system and
thereby reduce the symptoms of heart failure. Barostim received the
FDA Breakthrough Device designation and is FDA-approved for use in
heart failure patients in the U.S. It has also received the CE Mark
for heart failure and resistant hypertension in the European
Economic Area. To learn more about Barostim, visit
www.cvrx.com.
Investor Contact:
Mark Klausner or Mike VallieICR
Westwicke443-213-0501ir@cvrx.com
Media Contact:
Laura O’NeillFinn
Partners402-499-8203laura.oneill@finnpartners.com
CVRx (NASDAQ:CVRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
CVRx (NASDAQ:CVRX)
Historical Stock Chart
From Sep 2023 to Sep 2024